Reply - 01/07/16
Doi : 10.1016/j.jaci.2015.12.1349
Le texte complet de cet article est disponible en PDF.
Le texte complet de cet article est disponible en PDF.
| T.C. was cosponsored by the Center for Basic and Translational Research on Disorders of the Digestive System through the generosity of the Leona M. and Harry B. Helmsley Charitable Trust. J.G.K. was supported by the National Center for Research Resources (grant no. 5UL1RR024143-02), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. E.G.-Y. was supported by the Dermatology Foundation Physician Scientist Career Development Award. |
|
| Disclosure of potential conflict of interest: J. G. Krueger has received personal fees and/or money to his institution from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. E. Guttman-Yassky has board memberships with Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgen, Anacor, and Leo Pharma; has consultant arrangements with Regeneron, Sanofi Aventis, MedImmune, Celgen, Steifel/GlaxoSmithKline, Celsus, BMS, Amgen, and Drais; and has received grants from Regeneron, Celgene, BMS, and Janssen. T. Czarnowicki declares no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 138 - N° 1
P. 318-320 - juillet 2016 Retour au numéro
Article précédent
- Systemic B-cell abnormalities in patients with atopic dermatitis?
- Jorn J. Heeringa, Enes Hajdarbegovic, H. Bing Thio, Menno C. van Zelm
- Correction
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?